Biggest News Aggregation in the World
๐Ÿ“ฐ Epic Pharma News

Page 3 - Epic Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Epic Pharma. Real-time updates on events, politics, business and more.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical
Dennis Riedl Exchange Commission Lannett Company Epic Pharma Pharmaceuticals Inc Pharmaceuticals Inc View

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023

Financials for Third Quarter Fiscal Year 2023 Ended December 31, 2022 will be released on February 14, 2023NORTHVALE, NJ / ACCESSWIRE / February 8, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")
Schwierige Zeiten Exchange Commission Lannett Company Epic Pharma Pharmaceuticals Inc Pharmaceuticals Inc View

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

NORTHVALE, NJ / ACCESSWIRE / February 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported
Schwierige Zeiten Exchange Commission Lannett Company Epic Pharma Drug Administration Pharmaceuticals Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, November 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / November 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical
Exchange Commission Lannett Company Epic Pharma Pharmaceuticals Inc Pharmaceuticals Inc View Conference Call Scheduled

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence StudyNORTHVALE, NJ / ACCESSWIRE / November 2, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a
Exchange Commission Pharmaceuticals Reports Positive Lannett Company Epic Pharma Drug Administration Pharmaceuticals Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science